3 hours Insider Buying: Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Buys 10,000 Shares of StockMarketBeat
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) Director Bernd R. Seizinger bought 10,000 shares of the business’s stock in a transaction on Friday, October 11th. The shares were acquired at an average price of $2.68 per share, for a total tra…
X